$CB

O'Brien Frances D. sold (to issuer) 216 shares of CB

O'Brien Frances D. (Chief Risk Officer) sold (to issuer) 216 shares of Chubb Ltd (CB) on 2026-05-21.

Original reporting
SEC EDGAR · O'Brien Frances D.
Published May 26, 2026, 8:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 26, 2026, 8:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CB
Neutral
high confidence
Mentioned
$CB
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBNeutralLow
01

Why it matters

Because the price and total value are not disclosed and the transaction is a sale to the issuer, it provides limited signal about Chubb’s fundamentals or near-term risk outlook.

02

Market read

Traders may note the insider sale, but the lack of disclosed economics and the buyback/issuer-sale coding make it unlikely to drive sustained repricing.

03

What to watch

The transaction is coded as a sale to the issuer (often buyback-related) and may be administrative rather than a discretionary bearish bet; absence of disclosed price/value limits inference.

Relevance 3/10Timing: Immediate (filed 2026-05-26) but informationally limited for price discovery.

Background

The article is an SEC Form 4 insider transaction disclosure for Chubb Ltd (CB), filed 2026-05-26, showing a sale by the Chief Risk Officer.

Company-level read

Ticker impact

$CBNeutralHigh confidence
Context

Chubb (CB) disclosed an insider sale by Chief Risk Officer Frances D. O’Brien of 216 shares to the issuer on 2026-05-21.

Expected impact

Low near-term impact; any reaction is likely noise unless follow-on filings show a pattern.

Evidence & confidence

The filing provides only share count (216) with price/value not disclosed and describes a sale to the issuer; Form 4 insider activity often lacks directional information absent context or repeated selling.

Market effects

Minimal; single-insider Form 4 transactions rarely reset sector expectations for insurers.

None indicated; Chubb’s disclosure is company-specific.

None indicated; no cross-border deal/regulatory event mentioned.

Counterpoint

If additional insider filings show sustained selling by risk/finance leadership, the market could re-rate governance/risk appetite despite the lack of disclosed price here.

Key entities

  • Chubb Ltd

    Subject of the Form 4 insider transaction: 216 shares sold to the issuer by Chief Risk Officer Frances D. O’Brien.

  • Frances D. O’Brien

    Chubb Chief Risk Officer who reported the sale; holdings after transaction were 41,967 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBMed

Fed hikes again - an AI-Picked insurer is still cashing in

The Federal Reserve raised rates, impacting markets. Investing.com's AI models show varied portfolio performance. Chubb (CB) is benefiting from higher rates, with a 1.13% monthly gain, due to its Treasury investments. CB's earnings beat estimates, and it trades at a low forward P/E. The Fed's decision is affecting sectors differently.

$CBMed

Is Wall Street Bullish or Bearish on Chubb Limited Stock?

Chubb Limited (CB), a global insurer, has seen its stock rise 26% over the past year, outpacing the S&P 500. In 2026, it gained 10.2%, underperforming the index. CB offers a 1.20% dividend yield and has increased payouts for 18 years. Analysts expect 10.7% EPS growth this year. The consensus rating is 'Moderate Buy' with a mean price target of $369.36, suggesting 6.1% upside.

$CBMed

What Chubb (CB)'s Earnings Beat and Completed Buyback Mean For Shareholders

Chubb Limited (CB) reported Q2 2026 earnings above analyst estimates, citing higher underwriting and investment income and 3.6% net premium written growth across Property & Casualty and Life. The company also completed a US$4.45 billion multi-year buyback totaling 14,811,112 shares. Chubb Tempest Re named James Wixtead Executive Chairman and Michael O’Donnell President.

$BAXMed

This week in insurance: Catastrophe losses ease, Allianz buys HSBC Life Singapore, Chubb launches shopping cover

A weekly insurance roundup said Asia’s insured natural-catastrophe losses in H1 2026 were under $2.0b, the lowest six-month total since 2017, citing Gallagher Re. It also covered rising transaction-risk claims and new products. Deal news included Allianz buying HSBC Life Singapore for S$2.7b, and Sompo International agreeing to buy Fator Seguradora in Brazil.